CHOLANGIOCARCINOMA NON-RESECTABLE
Clinical trials for CHOLANGIOCARCINOMA NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new CHOLANGIOCARCINOMA NON-RESECTABLE trials appear
Sign up with your email to follow new studies for CHOLANGIOCARCINOMA NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted chemo infusion shows promise for hard-to-treat bile duct cancer
Disease control Recruiting nowThis study tests a chemotherapy cocktail (gemcitabine and oxaliplatin) delivered directly to the liver through a small tube. It is for people with bile duct cancer that has not spread but cannot be surgically removed, and who have already tried one standard treatment. The goal is…
Matched conditions: CHOLANGIOCARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New combo attack shows promise against tough bile duct cancer
Disease control Recruiting nowThis study is for people with a type of bile duct cancer that cannot be removed by surgery or has spread. It combines three treatments: tiny radioactive beads placed in the liver (Y-90), an immunotherapy drug (durvalumab), and two chemotherapy drugs (gemcitabine and cisplatin). T…
Matched conditions: CHOLANGIOCARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC